This site uses cookies.
Some of these cookies are essential, while others help us to improve your experience by providing insights into how the site is being used. For more detailed information on the cookies we use, please check our Cookie Policy
Cookie preferences
This website uses cookies so that we can provide you with the best user experience possible. Our Cookie Notice is part of our Cookie Policy and explains in detail how and why we use cookies. To take full advantage of our website, we recommend that you click on “Accept All”. You can change these settings at any time via the button "Update Cookie Preferences" in our Cookie Notice.
Necessary cookies (required)
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies
Analytical cookies help us to improve our website by collecting and reporting information on its usage.
Personalisation cookies
Personalisation cookies collect information about your website browsing habits and offer you a personalised user experience based on past visits, your location or browser settings. They also allow you to log in to personalised areas and to access third party tools that may be embedded in our website. Some functionality will not work if you don’t accept these cookies.
Solar Cells
With global annual temperature records being broken at an unprecedented rate, the need for immediate, concerted and multifaceted action to reduce carbon emissions into the Earth’s atmosphere whilst generating greater amounts of easily accessible and cheap energy to power a growing population is increasingly urgent.
Find out moreLeading innovations in chemistry and life sciences
Q&A with Jonathan Goodacre
To celebrate being named again as a recommended practitioner by IAM 1000, we talk to Jonathan Goodacre to discover why Cambridge is at the heart of the life sciences sector and how to solve the modern challenges of this evolving industry sector.
Find out moreIreland
A Growing Innovator in Nanotechnology and Medtech
Ireland is emerging as a leader in the world of nanotechnology and Medtech, positioning itself as a hub for innovation and research. Keltie's Seán Ryan delves into how Ireland is leading in these fields.
Find out moreInnovations in biotechnology & intellectual property
Q&A with Michael Moore
We talk to Mike to discover what makes a successful IP firm and how biotechnology is evolving. He discusses his journey into the field and talks about all things ‘AI’.
Find out moreKeltie’s journey to the top of Europe’s patent law firms
Q&A with Shakeel Ahmad
Shak discusses the IT challenges clients face today and learn how Keltie is helping them in this ever-evolving area. He discusses his career journey and how the Financial Times 2024 listings differ from other awards.
Find out moreKeltie ranked as one of Europe’s top Patent Law Firms
Financial Times 2024 listings
For the sixth time, Keltie is proud to be ranked as one of Europe’s leading Patent Law Firms in the Financial Times 2024 Listings.
Find out moreChampioning Diversity:
Jesús Enrique Vargas Millan on Pride Month
Discover Jesús Enrique Vargas Millan's story and Keltie's commitment to creating an inclusive workplace in our latest article.
Find out moreSMEs and Patents:
Unlocking Innovation and Economic Growth
In this article, Nathaniel Taylor sheds light on how SMEs (small and medium-sized enterprises) can mitigate cost issues to capitalise on their IP.
Find out morePatents, plausibility and data:
One year on from G 2/21
On 23 March 2023, the European Patent Office (EPO) Enlarged Board of Appeal (EBA) published its decision in case G 2/21, concerning plausibility in patent applications.
Find out moreManaging IP Europe Awards 2024
Keltie LLP Shines Bright
Keltie LLP announces the recognition of its outstanding legal team at the Managing IP Europe Awards 2024.
Find out morePrecision medicine, also referred to as personalised or stratified medicine, is an emerging approach for disease treatment and prevention in which medical decisions, treatments and products are tailored to a subgroup of patients by taking into account the individual characteristics of each patient.